Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Third Culture Capital (3CC) is a venture capital firm founded with a mission to support innovative entrepreneurs in the healthcare sector. Established in the United States, 3CC emphasizes the significance of unique life experiences in its investment strategy, aiming to challenge the status quo in established markets. The firm focuses on early-stage investments, specifically in companies that operate at the intersection of software and substrate, particularly in healthcare, biotech, and digital health sectors. With a portfolio comprising 15 companies, 3CC has established itself as a key player in the healthcare innovation landscape.
The firm operates with a check size range of $250,000 to $1 million, allowing it to provide substantial support to startups in their formative stages. 3CC's leadership is committed to empowering entrepreneurs who are dedicated to improving patient outcomes, reducing costs, and enhancing the overall experience of care for both patients and providers. This commitment to innovation and improvement in healthcare delivery sets 3CC apart in the venture capital space.
Third Culture Capital (3CC) specializes in investing in early-stage companies within the healthcare sector, particularly those that integrate software and substrate technologies. The firm is particularly interested in startups that can demonstrate a clear potential to improve patient outcomes and enhance care experiences. 3CC's investment strategy is centered around sectors such as healthcare, biotech, and digital health, reflecting a strong commitment to advancing healthcare innovation.
With an investment range of $250,000 to $1 million, 3CC seeks to back entrepreneurs who embody the principles of 'Third Culture'—those with diverse backgrounds and experiences that inform their approach to solving complex healthcare challenges. The firm looks for founders who are not only innovative but also possess a deep understanding of the healthcare landscape and the needs of patients and providers alike. By focusing on these criteria, 3CC aims to foster a new generation of healthcare solutions that are both effective and sustainable.
Third Culture Capital (3CC) boasts a diverse portfolio of 15 innovative companies that are making significant strides in the healthcare sector. Notable investments include AcousticaBio, recognized for its advancements in manufacturing for life sciences; Aviwell, a pioneering microbiome discovery platform aimed at enhancing food sustainability; and Binkey, which specializes in healthcare payment processing solutions. Additionally, Boswell provides essential services for underserved families, showcasing 3CC's commitment to social impact.
Other companies in the portfolio include Ciba Health, Docosan, Helm Health, Intus Care, KeyWise, Lime, Mahmee, Pragma Bio, Simplifed, Voiceitt, Vitaa, and Zuri Fertility. Each of these companies reflects 3CC's focus on healthcare innovation and its dedication to supporting entrepreneurs who are poised to transform the industry. The firm's strategic investments are designed to empower these startups to achieve their goals and drive meaningful change in healthcare delivery.
To pitch to Third Culture Capital, founders should visit their website at thirdculturecapital.com. The firm is open to both warm introductions and cold applications, and they encourage pitches that align with their focus on healthcare innovation.
Third Culture Capital primarily invests in early-stage companies, focusing on pre-seed, seed, and seed-plus stages. This allows them to support startups at critical points in their development.
Founders interested in pitching to Third Culture Capital can do so through their website at thirdculturecapital.com. The firm encourages entrepreneurs to present innovative ideas that align with their focus on healthcare innovation.
Third Culture Capital concentrates on the healthcare sector, specifically within healthcare, biotech, and digital health. They seek companies that operate at the intersection of software and substrate technologies.
The typical check size for investments made by Third Culture Capital ranges from $250,000 to $1 million, depending on the specific needs and potential of the startup.
Third Culture Capital primarily invests in companies based in the United States, focusing on startups that are innovating within the healthcare sector.
To apply for funding from Third Culture Capital, founders should visit their website and follow the guidelines provided for submitting a pitch. The firm is open to both warm introductions and cold applications.
While specific details on portfolio support are not outlined, Third Culture Capital is committed to empowering entrepreneurs and enhancing their chances of success through strategic investments and guidance.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.